These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18271941)

  • 1. Novel application of multicellular layers culture for in situ evaluation of cytotoxicity and penetration of paclitaxel.
    Al-Abd AM; Lee JH; Kim SY; Kun N; Kuh HJ
    Cancer Sci; 2008 Feb; 99(2):423-31. PubMed ID: 18271941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penetration of paclitaxel and 5-fluorouracil in multicellular layers of human colorectal cancer cells.
    Choi MS; Kim SH; Kuh HJ
    Oncol Rep; 2011 Mar; 25(3):863-70. PubMed ID: 21225235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The distribution and retention of paclitaxel and doxorubicin in multicellular layer cultures.
    Lee JH; Na K; Song SC; Lee J; Kuh HJ
    Oncol Rep; 2012 Apr; 27(4):995-1002. PubMed ID: 22267208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy.
    Tannock IF; Lee CM; Tunggal JK; Cowan DS; Egorin MJ
    Clin Cancer Res; 2002 Mar; 8(3):878-84. PubMed ID: 11895922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-nuclear localization of Ki-67 in human colorectal cancer cells grown as multicellular layers.
    Kim YJ; Lee SH; Lee J; Kuh HJ
    Arch Pharm Res; 2013 May; 36(5):634-40. PubMed ID: 23536320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-tumoral drug concentration mapping within solid tumor micro-milieu using in-vitro model and doxorubicin as a model drug.
    Al-Abd AM; Khedr A; Atteiah SG; Al-Abbasi FA
    Saudi Pharm J; 2020 Jun; 28(6):754-762. PubMed ID: 32550808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of paclitaxel penetration and accumulation in human solid tumor.
    Kuh HJ; Jang SH; Wientjes MG; Weaver JR; Au JL
    J Pharmacol Exp Ther; 1999 Aug; 290(2):871-80. PubMed ID: 10411604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of drug exposure parameters on the activity of paclitaxel in multicellular spheroids.
    Nicholson KM; Bibby MC; Phillips RM
    Eur J Cancer; 1997 Jul; 33(8):1291-8. PubMed ID: 9301458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative recording of vitality patterns in living multicellular spheroids by confocal microscopy.
    Wartenberg M; Acker H
    Micron; 1995; 26(5):395-404. PubMed ID: 8640359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of P-glycoprotein does influence the distribution of novel fluorescent compounds in solid tumour models.
    Martin C; Walker J; Rothnie A; Callaghan R
    Br J Cancer; 2003 Oct; 89(8):1581-9. PubMed ID: 14562035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of paclitaxel priming on doxorubicin penetration in a multicellular layer model of human colorectal cancer cells.
    Kim KS; Kim SH; Im CN; Na K; Lee MY; Park JK; Kuh HJ
    Biochem Biophys Res Commun; 2023 Mar; 647():30-36. PubMed ID: 36709670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of paclitaxel uptake, accumulation and retention in solid tumors.
    Jang SH; Wientjes MG; Au JL
    Invest New Drugs; 2001 May; 19(2):113-23. PubMed ID: 11392446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of interstitial protein delivery in multicellular layers model.
    Kim SY; Kim TH; Choi JH; Lee KC; Park KD; Lee SJ; Kuh HJ
    Arch Pharm Res; 2012 Mar; 35(3):531-41. PubMed ID: 22477201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of fluidizing agents on paclitaxel penetration in cervical cancerous monolayer membranes.
    Preetha A; Huilgol N; Banerjee R
    J Membr Biol; 2007 Oct; 219(1-3):83-91. PubMed ID: 17712507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity of paclitaxel incorporated in PLGA nanoparticles on hypoxic human tumor cells.
    Jin C; Bai L; Wu H; Song W; Guo G; Dou K
    Pharm Res; 2009 Jul; 26(7):1776-84. PubMed ID: 19384463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel.
    Hamaguchi T; Matsumura Y; Suzuki M; Shimizu K; Goda R; Nakamura I; Nakatomi I; Yokoyama M; Kataoka K; Kakizoe T
    Br J Cancer; 2005 Apr; 92(7):1240-6. PubMed ID: 15785749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation, Pharmacokinetic Evaluation and Cytotoxicity of an Enhanced- penetration Paclitaxel Nanosuspension.
    Cao Y; Wei Z; Li M; Wang H; Yin L; Chen D; Wang Y; Chen Y; Yuan Q; Pu X; Zong L; Duan S
    Curr Cancer Drug Targets; 2019; 19(4):338-347. PubMed ID: 29956630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Albumin-bound nanoparticle (nab) paclitaxel exhibits enhanced paclitaxel tissue distribution and tumor penetration.
    Chen N; Brachmann C; Liu X; Pierce DW; Dey J; Kerwin WS; Li Y; Zhou S; Hou S; Carleton M; Klinghoffer RA; Palmisano M; Chopra R
    Cancer Chemother Pharmacol; 2015 Oct; 76(4):699-712. PubMed ID: 26231955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes.
    Crosasso P; Ceruti M; Brusa P; Arpicco S; Dosio F; Cattel L
    J Control Release; 2000 Jan; 63(1-2):19-30. PubMed ID: 10640577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel-loaded expansile nanoparticles enhance chemotherapeutic drug delivery in mesothelioma 3-dimensional multicellular spheroids.
    Lei H; Hofferberth SC; Liu R; Colby A; Tevis KM; Catalano P; Grinstaff MW; Colson YL
    J Thorac Cardiovasc Surg; 2015 May; 149(5):1417-24; discussion 1424-25.e1. PubMed ID: 25841659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.